Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
Alembic Pharmaceuticals Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Woman ready to give informed consent for participation in study.
Exclusion criteria
Exclusion criteria: a. Women with history of Progesterone (Natural or synthetic) use in the last 3 months b. History of tubal insufficiency or obstruction including Endometriosis or Polycystic Ovarian Syndrome, c. History of AST and, or ALT greater than 2.5 x ULN (active liver disease), d. History of Serum creatinine greater than 1.5 mg per dl (active renal disease), e. History of Uncontrolled hypertension, hypercholesterolemia or diabetes, f. History of Psychoactive disease or on antidepressants, g. History of Smoking h. History of Myocardial infarction, stroke, cardiovascular or circulatory or clotting disorders i. History of Oral anticoagulants or prolonged use of high doses of NSAIDs, j. Hypersensitivity to Natural micronized progesterone k. Any condition that, in the opinion of the investigator, does not justify the patient’s inclusion in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum Progesterone(P)levels(ng/ml)Timepoint: Day 0 and Day 5 | — |
Secondary
| Measure | Time frame |
|---|---|
| NATimepoint: NA | — |
Countries
India
Contacts
Public ContactPallavi Singh
Rajendra Nagar Hospital and IVF center
Outcome results
None listed